NanoCarry

Delivery straight to the brain

NanoCarry offers a unique theranostic approach of a nanoparticle-based platform that can efficiently overcome the restrictive mechanism of the Blood-Brain-Barrier (BBB), and deliver bio-therapeutics into the brain. Our commitment to alleviate the suffering of patients with neurological disorders,  remains the key driving force behind our Biotechnology Startup. Our team of professionals is here to inspire you with their unique ideas and abilities.

Our Innovative Technology

NanoCarry aims to alleviate the suffering of patients with neurological disorders, by combining known disease targets and compounds together with an established drug delivery technology for safe targeting. Our nanoparticle-based platform  allows precise targeting of prominent molecular pathways, cells, and tissue types involved in the disease. NanoCarry's hybrid nanoparticles are based on an innovative, patent-protected drug delivery and imaging technique. This versatile nanoplatform technology can be applied to a pipeline of products, with the potential for a transformative impact on the treatment of a broad spectrum of neurological conditions, such as Alzheimer's, Parkinson's and ALS, as well as brain cancer and rare genetic diseases.